PolyPid Announces Proposed Underwritten Public Offering of Ordinary Shares

PETACH TIKVA, Israel, March 28, 2023 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, announced today that it has commenced an underwritten public offering of its ordinary shares, no par value (the